Cerebrospinal fluid levels of neuroinflammatory biomarkers are increased in athletes with persistent post-concussive symptoms following sports-related concussion.

Biomarkers Cerebrospinal fluid Chemokines Concussion Cytokines Neuroinflammation Persisting post-concussive symptoms Sport

Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
17 Aug 2023
Historique:
received: 17 05 2023
accepted: 29 07 2023
medline: 21 8 2023
pubmed: 18 8 2023
entrez: 17 8 2023
Statut: epublish

Résumé

A sports-related concussion (SRC) is often caused by rapid head rotation at impact, leading to shearing and stretching of axons in the white matter and initiation of secondary inflammatory processes that may exacerbate the initial injury. We hypothesized that athletes with persistent post-concussive symptoms (PPCS) display signs of ongoing neuroinflammation, as reflected by altered profiles of cerebrospinal fluid (CSF) biomarkers, in turn relating to symptom severity. We recruited athletes with PPCS preventing sports participation as well as limiting work, school and/or social activities for ≥ 6 months for symptom rating using the Sport Concussion Assessment Tool, version 5 (SCAT-5) and for cognitive assessment using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Following a spinal tap, we analysed 27 CSF inflammatory biomarkers (pro-inflammatory chemokines and cytokine panels) by a multiplex immunoassay using antibodies as electrochemiluminescent labels to quantify concentrations in PPCS athletes, and in healthy age- and sex-matched controls exercising ≤ 2 times/week at low-to-moderate intensity. Thirty-six subjects were included, 24 athletes with PPCS and 12 controls. The SRC athletes had sustained a median of five concussions, the most recent at a median of 17 months prior to the investigation. CSF cytokines and chemokines levels were significantly increased in eight (IL-2, TNF-α, IL-15, TNF-β, VEGF, Eotaxin, IP-10, and TARC), significantly decreased in one (Eotaxin-3), and unaltered in 16 in SRC athletes when compared to controls, and two were un-detectable. The SRC athletes reported many and severe post-concussive symptoms on SCAT5, and 10 out of 24 athletes performed in the impaired range (Z < - 1.5) on cognitive testing. Individual biomarker concentrations did not strongly correlate with symptom rating or cognitive function. Limitations include evaluation at a single post-injury time point in relatively small cohorts, and no control group of concussed athletes without persisting symptoms was included. Based on CSF inflammatory marker profiling we find signs of ongoing neuroinflammation persisting months to years after the last SRC in athletes with persistent post-concussive symptoms. Since an ongoing inflammatory response may exacerbate the brain injury these results encourage studies of treatments targeting the post-injury inflammatory response in sports-related concussion.

Identifiants

pubmed: 37592277
doi: 10.1186/s12974-023-02864-0
pii: 10.1186/s12974-023-02864-0
pmc: PMC10433539
doi:

Substances chimiques

Cytokines 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189

Subventions

Organisme : Swedish Brain Foundation
ID : FO2022-0154

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

McCrory P, Feddermann-Demont N, Dvorak J, et al. What is the definition of sports-related concussion: a systematic review. Br J Sports Med. 2017;51:877–87.
pubmed: 29098981 doi: 10.1136/bjsports-2016-097393
Vedantam A, Brennan J, Levin HS, et al. Early versus late profiles of inflammatory cytokines after mild traumatic brain injury and their association with neuropsychological outcomes. J Neurotrauma. 2021;38:53–62.
pubmed: 32600167 doi: 10.1089/neu.2019.6979
Schwab N, Grenier K, Hazrati LN. DNA repair deficiency and senescence in concussed professional athletes involved in contact sports. Acta Neuropathol Commun. 2019;7:182.
pubmed: 31727161 pmcid: 6857343 doi: 10.1186/s40478-019-0822-3
Tang-Schomer MD, Johnson VE, Baas PW, Stewart W, Smith DH. Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp Neurol. 2012;233:364–72.
pubmed: 22079153 doi: 10.1016/j.expneurol.2011.10.030
Patterson ZR, Holahan MR. Understanding the neuroinflammatory response following concussion to develop treatment strategies. Front Cell Neurosci. 2012;6:58.
pubmed: 23248582 pmcid: 3520152 doi: 10.3389/fncel.2012.00058
Batchelder BC, Krause BA, Seegmiller JG, Starkey CA. Gastrointestinal temperature increases and hypohydration exists after collegiate men’s ice hockey participation. J Strength Cond Res. 2010;24:68–73.
pubmed: 20042926 doi: 10.1519/JSC.0b013e3181c49114
Sakurai A, Atkins CM, Alonso OF, Bramlett HM, Dietrich WD. Mild hyperthermia worsens the neuropathological damage associated with mild traumatic brain injury in rats. J Neurotrauma. 2012;29:313–21.
pubmed: 22026555 pmcid: 3261791 doi: 10.1089/neu.2011.2152
Bonds BW, Hu P, Li Y, et al. Predictive value of hyperthermia and intracranial hypertension on neurological outcomes in patients with severe traumatic brain injury. Brain Inj. 2015;29:1642–7.
pubmed: 26479461 doi: 10.3109/02699052.2015.1075157
Tator CH, Davis HS, Dufort PA, et al. Postconcussion syndrome: demographics and predictors in 221 patients. J Neurosurg. 2016;125:1206–16.
pubmed: 26918481 doi: 10.3171/2015.6.JNS15664
Hiploylee C, Dufort PA, Davis HS, et al. Longitudinal study of postconcussion syndrome: not everyone recovers. J Neurotrauma. 2017;34:1511–23.
pubmed: 27784191 pmcid: 5397249 doi: 10.1089/neu.2016.4677
Shahim P, Tegner Y, Gustafsson B, et al. Neurochemical aftermath of repetitive mild traumatic brain injury. JAMA Neurol. 2016;73:1308–15.
pubmed: 27654934 doi: 10.1001/jamaneurol.2016.2038
Shahim P, Zetterberg H. Neurochemical markers of traumatic brain injury: relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction. Biol Psychiatry. 2022;91:405–12.
pubmed: 34857362 doi: 10.1016/j.biopsych.2021.10.010
Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22:142–9.
pubmed: 21714827 doi: 10.1111/j.1750-3639.2011.00513.x
Marklund N, Vedung F, Lubberink M, et al. Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients—a PET/MR study. Neuroimage Clin. 2021;30: 102665.
pubmed: 33894460 pmcid: 8091173 doi: 10.1016/j.nicl.2021.102665
Isung J, Granqvist M, Trepci A, et al. Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects. Sci Rep. 2021;11:1669.
pubmed: 33462306 pmcid: 7814004 doi: 10.1038/s41598-021-81306-4
Sport concussion assessment tool, 5th edn. Br J Sports Med. 2017;51:851–8.
Echemendia RJ, Meeuwisse W, McCrory P, et al. The Sport Concussion Assessment Tool 5th Edition (SCAT5): background and rationale. Br J Sports Med. 2017;51:848–50.
pubmed: 28446453
Randolph C. Repeatable battery for the assessment of neuropsychological status—RBANS. Stockholm: Pearson Assessment; 2013.
Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20:310–9.
pubmed: 9845158 doi: 10.1076/jcen.20.3.310.823
McKay C, Casey JE, Wertheimer J, Fichtenberg NL. Reliability and validity of the RBANS in a traumatic brain injured sample. Arch Clin Neuropsychol. 2007;22:91–8.
pubmed: 17141467 doi: 10.1016/j.acn.2006.11.003
Pachet AK. Construct validity of the Repeatable Battery of Neuropsychological Status (RBANS) with acquired brain injury patients. Clin Neuropsychol. 2007;21:286–93.
pubmed: 17455019 doi: 10.1080/13854040500376823
Feng C, Wang H, Lu N, et al. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry. 2014;26:105–9.
pubmed: 25092958 pmcid: 4120293
Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62:1160–3; discussion 7.
pubmed: 16009779 doi: 10.1001/archneur.62.7.1160
Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron. 2017;95:1246–65.
pubmed: 28910616 pmcid: 5678753 doi: 10.1016/j.neuron.2017.07.010
Engel S, Schluesener H, Mittelbronn M, et al. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol. 2000;100:313–22.
pubmed: 10965802 doi: 10.1007/s004019900172
Witcher KG, Bray CE, Chunchai T, et al. Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J Neurosci. 2021;41:1597–616.
pubmed: 33452227 pmcid: 7896020 doi: 10.1523/JNEUROSCI.2469-20.2020
Johnson VE, Stewart JE, Begbie FD, et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136:28–42.
pubmed: 23365092 pmcid: 3562078 doi: 10.1093/brain/aws322
Ramlackhansingh AF, Brooks DJ, Greenwood RJ, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70:374–83.
pubmed: 21710619 doi: 10.1002/ana.22455
Jacquens A, Needham EJ, Zanier ER, Degos V, Gressens P, Menon D. Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side. Int J Mol Sci. 2022;23(19):11193.
pubmed: 36232495 pmcid: 9570205 doi: 10.3390/ijms231911193
Goldstein LE, Fisher AM, Tagge CA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4:134ra60.
pubmed: 22593173 pmcid: 3739428
Yang SH, Gustafson J, Gangidine M, et al. A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J Surg Res. 2013;184:981–8.
pubmed: 23622728 pmcid: 4073786 doi: 10.1016/j.jss.2013.03.075
Yang SH, Gangidine M, Pritts TA, Goodman MD, Lentsch AB. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice. Shock. 2013;40:471–5.
pubmed: 24088994 pmcid: 4218737 doi: 10.1097/SHK.0000000000000037
Drieu A, Lanquetin A, Prunotto P, et al. Persistent neuroinflammation and behavioural deficits after single mild traumatic brain injury. J Cereb Blood Flow Metab. 2022;42:2216–29.
pubmed: 35945692 pmcid: 9670002 doi: 10.1177/0271678X221119288
Mouzon BC, Bachmeier C, Ferro A, et al. Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann Neurol. 2014;75:241–54.
pubmed: 24243523 doi: 10.1002/ana.24064
Mouzon BC, Bachmeier C, Ojo JO, et al. Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury. Ann Clin Transl Neurol. 2018;5:64–80.
pubmed: 29376093 doi: 10.1002/acn3.510
Shultz SR, Bao F, Omana V, et al. Repeated mild lateral fluid percussion brain injury in the rat causes cumulative long-term behavioral impairments, neuroinflammation, and cortical loss in an animal model of repeated concussion. J Neurotrauma. 2012;29:281–94.
pubmed: 21933013 doi: 10.1089/neu.2011.2123
Webster KM, Wright DK, Sun M, et al. Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury. J Neuroinflamm. 2015;12:238.
doi: 10.1186/s12974-015-0457-7
Huie JR, Diaz-Arrastia R, Yue JK, et al. Testing a multivariate proteomic panel for traumatic brain injury biomarker discovery: a TRACK-TBI pilot study. J Neurotrauma. 2019;36:100–10.
pubmed: 30084741 doi: 10.1089/neu.2017.5449
Meier TB, Huber DL, Bohorquez-Montoya L, et al. A prospective study of acute blood-based biomarkers for sport-related concussion. Ann Neurol. 2020;87:907–20.
pubmed: 32215965 pmcid: 7477798 doi: 10.1002/ana.25725
Chaban V, Clarke GJB, Skandsen T, et al. Systemic inflammation persists the first year after mild traumatic brain injury: results from the prospective trondheim mild traumatic brain injury study. J Neurotrauma. 2020;37:2120–30.
pubmed: 32326805 pmcid: 7502683 doi: 10.1089/neu.2019.6963
Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2011;31:658–70.
pubmed: 20717122 doi: 10.1038/jcbfm.2010.142
Tobieson L, Gard A, Ruscher K, Marklund N. Intracerebral proinflammatory cytokine increase in surgically evacuated intracerebral hemorrhage: a microdialysis study. Neurocrit Care. 2022;36:876–87.
pubmed: 34850333 doi: 10.1007/s12028-021-01389-9
Coughlin JM, Wang Y, Munro CA, et al. Neuroinflammation and brain atrophy in former NFL players: an in vivo multimodal imaging pilot study. Neurobiol Dis. 2015;74:58–65.
pubmed: 25447235 doi: 10.1016/j.nbd.2014.10.019
Coughlin JM, Wang Y, Minn I, et al. Imaging of glial cell activation and white matter integrity in brains of active and recently retired national football league players. JAMA Neurol. 2017;74:67–74.
pubmed: 27893897 pmcid: 5504689 doi: 10.1001/jamaneurol.2016.3764
Bignami A, Eng LF, Dahl D, Uyeda CT. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 1972;43:429–35.
pubmed: 4559710 doi: 10.1016/0006-8993(72)90398-8
McCrea M, Broglio SP, McAllister TW, et al. Association of blood biomarkers with acute sport-related concussion in collegiate athletes: findings from the NCAA and Department of Defense CARE Consortium. JAMA Netw Open. 2020;3: e1919771.
pubmed: 31977061 pmcid: 6991302 doi: 10.1001/jamanetworkopen.2019.19771
Shahim P, Politis A, van der Merwe A, et al. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Neurology. 2020;95:e623–36.
pubmed: 32641529 pmcid: 7455355 doi: 10.1212/WNL.0000000000009985
Cherry JD, Tripodis Y, Alvarez VE, et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2016;4:112.
pubmed: 27793189 pmcid: 5084333 doi: 10.1186/s40478-016-0382-8
Collins-Praino LE, Arulsamy A, Katharesan V, Corrigan F. The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury. Behav Brain Res. 2018;336:22–31.
pubmed: 28855139 doi: 10.1016/j.bbr.2017.08.035
Holleran L, Kim JH, Gangolli M, et al. Axonal disruption in white matter underlying cortical sulcus tau pathology in chronic traumatic encephalopathy. Acta Neuropathol. 2017;133:367–80.
pubmed: 28214960 doi: 10.1007/s00401-017-1686-x
Cavaillon JM. Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol (Noisy-le-grand). 2001;47:695–702.
pubmed: 11502077
Di Battista AP, Rhind SG, Richards D, et al. Altered blood biomarker profiles in athletes with a history of repetitive head impacts. PLoS ONE. 2016;11: e0159929.
pubmed: 27458972 pmcid: 4961456 doi: 10.1371/journal.pone.0159929
Di Battista AP, Churchill N, Schweizer TA, et al. Blood biomarkers are associated with brain function and blood flow following sport concussion. J Neuroimmunol. 2018;319:1–8.
pubmed: 29685283 doi: 10.1016/j.jneuroim.2018.03.002
O’Brien WT, Symons GF, Bain J, et al. Elevated serum interleukin-1beta levels in male, but not female, collision sport athletes with a concussion history. J Neurotrauma. 2021;38:1350–7.
pubmed: 33308001 doi: 10.1089/neu.2020.7479
Perneger TV. What’s wrong with Bonferroni adjustments. BMJ. 1998;316:1236–8.
pubmed: 9553006 pmcid: 1112991 doi: 10.1136/bmj.316.7139.1236

Auteurs

Anna Gard (A)

Department of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.

Fredrik Vedung (F)

Department of Neuroscience, Neurosurgery, Uppsala University, Uppsala, Sweden.

Fredrik Piehl (F)

Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Mohsen Khademi (M)

Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Maria Portonova Wernersson (MP)

Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.

Ia Rorsman (I)

Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.

Yelverton Tegner (Y)

Department of Health Sciences, Luleå University of Technology, Luleå, Sweden.

Hélène Pessah-Rasmussen (H)

Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.
Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.

Karsten Ruscher (K)

Department of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden.

Niklas Marklund (N)

Department of Clinical Sciences Lund, Neurosurgery, Lund University, Lund, Sweden. niklas.marklund@med.lu.se.
Department of Clinical Sciences Lund, Neurosurgery, Lund University, Skåne University Hospital EA-Blocket Plan 4, Klinikgatan 17A7, 221 85, Lund, Sweden. niklas.marklund@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH